Showing results (91-100 of 115) with videos related to
Sort By:
Pageof 12
Scientific Reports|July 28, 2019
The influence of Echinacea purpurea leaf microbiota on chicoric acid levelValentina Maggini, Marinella De Leo, Carlotta Granchi, et al.Oncoscience|April 22, 2021
Correction: Lactate dehydrogenase A inhibition by small molecular entities: steps in the right directionBtissame El Hassouni, Marika Franczak, Mjriam Capula, et al.Oncoscience|November 16, 2020
Lactate dehydrogenase A inhibition by small molecular entities: steps in the right directionBtissame El Hassouni, Marika Franczak, Mjriam Capula, et al.International Journal of Molecular Sciences|May 13, 2023
Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant MesotheliomaMarika A Franczak, Oliwia Krol, Gabriela Harasim, et al.European Journal of Medicinal Chemistry|April 13, 2011
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximesSimone Bertini, Andrea De Cupertinis, Carlotta Granchi, et al.Bioorganic & Medicinal Chemistry Letters|November 8, 2011
Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5Carlotta Granchi, Sarabindu Roy, Marco Mottinelli, et al.Chembiochem : a European Journal of Chemical Biology|November 1, 2013
Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitorEmilia C Calvaresi, Carlotta Granchi, Tiziano Tuccinardi, et al.Journal of Medicinal Chemistry|January 9, 2009
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor betaFilippo Minutolo, Simone Bertini, Carlotta Granchi, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
New PIN1 inhibitors identified through a pharmacophore-driven, hierarchical consensus docking strategyGiulio Poli, Miriana Di Stefano, Joan Arias Estevez, et al.RSC Advances|July 14, 2015
Synthesis and biological evaluation of non-glucose glycoconjugated <i>N</i>-hydroyxindole class LDH inhibitors as anticancer agentsValeria Di Bussolo, Emilia C Calvaresi, Carlotta Granchi, et al.Pageof 12